As of the latest Form 4 filed Jun 10, 2026.
What Cibus Global LLC insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 20 most recent filings for CBUS.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-10 | 2026-06-08 | Wichner Craig CEO | AAward | +894K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-04 | 2026-06-02 | Prante Gerhard Director | AAward | +64.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-04 | 2026-06-02 | Lehmann Jean-Pierre Jules Director | AAward | +64.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-04 | 2026-06-02 | Urban Thomas Director | AAward | +64.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-28 | 2026-04-24 | Sauer Noel Sr VP, Research | AAward | +38.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-28 | 2026-04-24 | Stokes Jason CAO, Gen Csl & Corp Secy | AAward | +57.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-28 | 2026-04-24 | Broos Carlo CFO | AAward | +57.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-28 | 2026-04-24 | Gocal Gregory Francis William Chief Scientific Officer & EVP | AAward | +57.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-28 | 2026-04-24 | Beetham Peter Interim CEO, Pres & COO | AAward | +195K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-01 | 2026-03-30 | Sauer Noel Sr VP, Research | FTax | −1.76K | $1.84 | $3.24K | No | Form 4 ↗ |
| 2026-04-01 | 2026-03-30 | Stokes Jason CLO, Gen Csl & Secy | FTax | −3.69K | $1.83 | $6.76K | No | Form 4 ↗ |
| 2026-04-01 | 2026-03-30 | Broos Carlo CFO | FTax | −3.68K | $1.87 | $6.87K | No | Form 4 ↗ |
| 2026-04-01 | 2026-03-30 | Gocal Gregory Francis William Chief Scientific Officer & EVP | FTax | −8.95K | $1.82 | $16.3K | No | Form 4 ↗ |
| 2026-04-01 | 2026-03-30 | Beetham Peter Interim CEO, Pres & COO | FTax | −16.1K | $1.85 | $29.8K | No | Form 4 ↗ |
| 2026-03-18 | 2026-02-19 | Stokes Jason CLO, Gen Csl & Secy | FTax | −4.79K | $2.98 | $14.3K | No | Form 4 ↗ |
| 2026-03-18 | 2025-11-11 | Broos Carlo CFO | FTax | −1.50K | $1.32 | $1.97K | No | Form 4 ↗ |
| 2026-03-18 | 2025-11-11 | Sauer Noel Sr VP, Research | FTax | −1.83K | $1.32 | $2.42K | No | Form 4 ↗ |
| 2026-03-18 | 2025-11-11 | Stokes Jason CLO, Gen Csl & Secy | FTax | −3.52K | $1.32 | $4.65K | No | Form 4 ↗ |
| 2026-03-18 | 2025-06-13 | Sauer Noel Sr VP, Research | SSale | −4.00 | $1.49 | $5.94 | No | Form 4 ↗ |
| 2026-03-18 | 2025-02-19 | Stokes Jason CLO, Gen Csl & Secy | FTax | −4.79K | $2.33 | $11.1K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also CBUS’s full analysis or the market-wide insider trading feed. The tabs above jump to CBUS’s other SEC data.
Source: SEC Form 4 filings for CBUS, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.